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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A210reliability. We validated the lateral CDI by examining the association
between baseline (month 0) lateral CDI, lateral joint space narrowing
(OARSI score 0-1), lateral joint space width (JSW), and static alignment
(hip-knee-ankle [HKA] angle). We calculated standard response mean
(SRM) for lateral CDI change between baseline and 24-months. JSW
data and descriptions of the methods are publicly available on the OAI
website (kxr_qjsw_duryea_00 [version 0.5] and kxr_qjsw_duryea_03
[version 3.4]; http://oai.epi-ucsf.org/). HKA was measured on standing
full-limb radiographs (developed by Derek Cooke, ICC>0.99).
Results: The ﬁnal validation set included 100 knees with a mean age:
64.3 years, 59% females, and with a diverse range of lateral JSN grades (0
to 3, each grade contains 25 subjects) as our ﬁnal validation dataset. The
intra-tester reliability is good (intraclass correlation coefﬁcient ICC [3, 1
model] ¼ 0.86 to 0.98). At baseline, knees with greater medial JSN and
KL had lower mean CDI (i.e. greater cartilage damage, Table 1). Baseline
lateral CDI is associated with both lateral JSW and HKA (see table 2).The
SRM is good (SRM¼-0.76 for lateral femur; SRM¼-0.73 for lateral tibia;
SRM¼-0.87 for lateral tibiofemoral total).Table 1
Baseline lateral cartilage damage index stratiﬁed by baseline lateral JSN and KL grade.
Lateral JSN
Cartilage Measure JSN¼0 (n¼25) mean JSN¼1 (n¼25) mean JSN¼2 (n¼25) mean JSN¼2 (n¼25) mean p-value for trend
Lateral Femur CDI 2969.3 3003.2 2184.4 1542.0 <0.001
Lateral Tibia CDI 1154.9 889.9 663.8 392.7 <0.001
Lateral Tibiofemoral CDI 4124.3 3893.0 2848.2 1934.6 <0.001
KL
KL¼0 (n¼10) mean KL¼1 (n¼6) mean KL¼2 (n¼32) mean KL¼3 (n¼26) mean KL¼4 (n¼26) mean p-value for trend
Lateral Femur CDI 2718.7 2831.5 3061.0 2254.0 1605.3 <0.001
Lateral Tibia CDI 1229.3 994.1 946.3 690.4 424.7 <0.001
Lateral Tibiofemoral CDI 3948.0 3825.5 4007.3 2944.4 2030.0 <0.001
Table 2
Spearman correlation of baseline lateral CDI with baseline lateral JSW and HKA
angle.
Cartilage Measure Lateral JSW HKA
Lateral Femur CDI 0.81* -0.31*
Lateral Tibia CDI 0.81* -0.30*
Lateral Tibiofemoral CDI 0.85* -0.33*
Note: * ¼ p<0.05.Conclusions: Overall, the lateral tibiofemoral CDI quantiﬁcation is
reliable, responsive, and has good construct valid. The CDI has utility for
deployment in large studies.
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CHANGE IN CARTILAGE T2 RELAXATION TIME IN OSTEOARTHRITIC
KNEES WITH AND WITHOUT STRUCTURAL PROGRESSION e PILOT
DATA FROM THE OSTEOARTHRITIS INITIATIVE
W.Wirth y,z, S. Maschek y,z, P. Beringer y, F. Eckstein y,z. y Paracelsus Med.
Univ. Salzburg & Nuremberg, Salzburg, Austria; zChondrometrics GmbH,
Ainring, GermanyBaseline T2 (ms) and change in T2 in the cartilages of progressors (P) and non-progre
Baseline Change
P NP P vs.NP P
Mean SD Mean SD P-Value Mean
MT Deep Layer 35.8 3.1 35.6 3.5 0.89 1.4
Superﬁcial Layer 44.8 3.0 43.6 2.9 0.12 -0.6
cMF Deep Layer 45.5 5.0 46.4 8.1 0.66 1.9
Superﬁcial Layer 54.0 4.3 51.6 4.7 0.09 0.4
LT Deep Layer 32.9 2.1 32.5 2.5 0.53 0.1
Superﬁcial Layer 43.0 2.9 43.3 3.1 0.74 -0.1
cLF Deep Layer 41.9 3.7 41.7 2.5 0.80 -0.3
Superﬁcial Layer 50.3 4.5 49.4 4.4 0.54 -1.1Purpose: MRI-based measurement of spin-spin (transverse) relaxation
time (T2) of articular cartilage is of interest because of its potential
sensitivity to changes in cartilage composition. However, it is unknown
whether cartilage T2 predicts structural progression (i.e. cartilage loss
in MRI and radiographic joint space width [JSW] loss) in knee osteo-
arthritis (OA), and to what extent T2 changes longitudinally in knees
that exhibit structural progression. The objective of the current study
was therefore to compare baseline cartilage T2 and longitudinal change
in T2 between knees with and without structural progression in the
medial femorotibial compartment.
Methods: OA knees with and without structural progression in the
medial femorotibial compartment (MFTC) were selected from a sub-
cohort of the OAI (n¼625), for which baseline and 1-year follow-up
measurements of MRI-based cartilage thickness and radiographic JSW
were available. 45 knees with Kellgren & Lawrence grade 2/3 showed
structural progression in the MFTC that exceeded the smallest detect-
able change (SDC) thresholds for both MRI-based cartilage thickness
(102mm) and radiographic JSW (328mm) over the same period. Of these,37 could be matched to one of the 202 knees from the same subcohort
without any progression in theMFTC or the lateral compartment (LFTC).
Knees were matched 1:1 by KLG, BMI, sex, and knee pain status.
Thus far, cartilage T2 analyses were completed in 22 of the 37 matched
case-control pairs (17 women/5 men; 13KLG 2/9 KLG3; cases: age:
63.8±9.0 y, BMI: 30.6±5.0 kg/m2; controls: 65.5±10.6 y, 30.8±4.4 kg/
m2). A multi-echo spin-echo MRI sequence was used (resolution:
0.31x0.31x3mm, repetition time: 2700ms, echo time: 10, 20, 30, 40, 50,
60, 70ms, 1st echo excluded from analysis) andmanual segmentation of
the medial and lateral tibial (MT/LT) and medial and lateral weight-
bearing femoral condyles (cMF/cLF) was performed with blinding to the
progressor/non-progressor status and the image acquisition order. T2
was computed in the deep and superﬁcial layer of each cartilage plate
(each 50% of the thickness) using a non-linear curve-ﬁtting. Paired t-
tests were used to compare baseline and follow-up measurements
within progressors and non-progressors, and to compare both groups
cross-sectionally (at baseline) and longitudinally.
Results: The baseline T2 did not differ signiﬁcantly between OA knees
with and without subsequent medial progression (p0.09, Table).
Despite the substantial cartilage thickness loss in the MFTC of the
progressors (Mean±SD: -280 ±160mm, p<0.001), no signiﬁcant change
in T2 was observed in MFTC (p0.10, Table). The T2 tended to increasessors (NP)
NP P vs. NP
SD P-Value (change) Mean SD P-Value (change) P-Value
3.9 0.10 -0.7 1.5 0.05 0.05
2.9 0.31 -0.1 2.1 0.83 0.42
5.4 0.11 -0.1 4.3 0.90 0.06
5.7 0.72 0.3 3.0 0.70 0.89
1.5 0.82 -0.1 1.3 0.60 0.61
1.6 0.86 -0.7 1.6 0.06 0.24
2.2 0.50 -0.5 1.7 0.20 0.74
2.1 0.03 -0.7 2.2 0.17 0.55
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A211in the deep layer of MT (þ1.4±3.9 ms, p¼0.10) and cMF (þ1.9±5.4ms;
p¼0.11) and tended to decrease in the LFTC, (Table); however, a sig-
niﬁcant reduction was only observed in the superﬁcial layer of the cLF
(-1.1±2.1 ms, p¼0.03 without adjusting for multiple comparisons).Non-
progressor knees maintained their MFTC cartilage thickness over the
one-year period (þ22±72mm) and in these knees, cartilage T2 tended to
decrease in both theMFTC and LFTC; however the changes did not reach
statistical signiﬁcance (p0.05, Table).
Further, longitudinal (1-year) change in T2 times did not differ sig-
niﬁcantly between progressors and non-progressors (Table), although
cartilage thickness change did (p <0.001 in MT and cMF). The differ-
ences in longitudinal change in the deep layer of MT and cMF, however,
were close to reaching statistical signiﬁcance (p¼0.05 and p¼0.06,
respectively).
Conclusions: This is the ﬁrst study analyzing cartilage T2 in OA knees
with subsequent structural progression and non-progressive controls. A
limitation is the small sample size, but strengths are that progressors
and non-progressors were selected from a relatively large sample of OA
knees using two independent methods (MRI and radiography), and that
these were matched 1:1 with controls based on radiographic disease
stage and demographic characteristics. The results are not suggestive of
cartilage T2 in either the deep or superﬁcial layer predicting structural
progression in the same compartment. Further, only relatively mild
differences were seen in the longitudinal rates change of cartilage T2
between progressors and non-progressor knees, despite dramatic dif-
ferences in medial cartilage loss between both groups. Future work will
explore whether differences in cartilage T2 beween progressor and
non-progressor knees become more obvious when extending the
analysis to a larger sample.
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ESTABLISHING A NON-HUMAN PRIMATE MODEL OF
OSTEOARTHRITIS USING TRANSLATIONAL ENDPOINTS
M. Wald y, P. Chandran y, G. Tao z, R. Tang z, D. Conlon x, E. Sampson x,
M. Honore y, R. Kamath x, S. Wang y, J. Medema y, J. Li y, G. Fox y, Y. Luo y.
yAbbVie Inc., North Chicago, IL, USA; zWincon TheraCells Biotechnologies,
Nanning, China; xAbbVie Inc, AbbVie Bioresearch Ctr., Worcester, MA, USA
Purpose: Current animal models of osteoarthritis (OA) have somewhat
limited translation value for developing disease-modifying OA drugs
(DMOADs) due to species and assessment related mismatches from
clinical OA. Here, we investigated the potential of a nonhuman primate
(NHP) surgical model of OA as a translational model by characterizing
longitudinal arthritic changes using quantitative and semi-quantitative
magnetic resonance imaging (MRI) scoring, serum biomarkers, pain
behavior tests and histology.
Methods: Six Cynomolgous macaques underwent surgical excision of
the right knee medial meniscus (MMT) and four age-/weight-matched
sham animals served as controls. MRI of the right knee joint were
performed longitudinally prior to surgery and at one, two, and four
months after surgery on a 3T Phillips MRI scanner using high resolution
T1- and T2-weighted protocols, and a dynamic contrast enhanced series.
Tibial and femoral cartilage plates were manually segmented and
divided into subregions for quantitative cartilage assessment. The semi-
quantitative MRI Osteoarthritis Knee Scoring (MOAKS) systemwas used
to assess the structural changes of the knee joint, and the uptake of Gd-
DTPA contrast agent was quantiﬁed in the regions of synovial tissue. OA
related pain behaviors including Von-frey, knee ﬂexion, and activity
monitoring were assessed using the same time schedule. Blood samples
were taken every two weeks to assess serum levels of CTX-1, HA, C2C,
and MMP3. Animals were sacriﬁced at four (3 MMT, 2 sham) and six
months (the remainder) post-surgery for histological evaluation of
cartilage degeneration, bone alterations, and synovial inﬂammation.
Group differences between MMT and sham were evaluated by a linear
mixed model of the change from baseline for the behavioral, cartilage
morphometry, and contrast enhancement rate measurements. Wil-
coxon rank sum test was used for MOAKS evaluation. Group differences
in histological assessments and biochemical biomarkers were analyzed
by ANOVA.
Results: Quantitative cartilage analysis depicted signiﬁcantly thinner
cartilage in the posterior medial femur ofMMTanimals at all timepoints
(p<0.0001) and in the central medial tibiofemoral compartment at two
months post surgery (p<0.05). Based on MOAKS scores, MMT animals
had more cartilage degradation than sham in the central medial tibia at
all timepoints (p<0.01) and in the central medial femur at one month(p<0.05) post-surgery. Hoffa-synovitis and whole knee effusion/syno-
vitis scores were signiﬁcantly higher in the MMT group with the
maximal difference occuring at three months post-surgery (p<0.01)
and abating thereafter. Higher contrast uptake rate was observed in
multiple subregions of synovial tissue (p<0.01) of MMT animals com-
pared to sham, peaking at two months post-surgery. Histological
analysis captured increased tibial and femoral medial cartilage degra-
dation in the MMT group relative to sham (p<0.05) with pronounced
osteophytes in all MMT animals. MMT animals demonstrated decreased
mobility relative to sham post-surgery (p<0.05). No signiﬁcant differ-
ences were detected in other behavioral measures or in any serum
biomarkers tested.
Conclusions: In this study, MRI joint assessment demonstrated carti-
lage loss and synovial inﬂammation, both hallmarks of OA progression.
These ﬁndings coupled with reduced physical activity and histological
conﬁrmation of OA-speciﬁc pathology are the ﬁrst reported ﬁndings in a
NHP model of surgically-induced OA. Additional assessment of this
model with pharmacological intervention will further elucidate the
utility of this novel translational platform for the development of
DMOADs.
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CORRELATION BETWEEN 3D JOINT SPACE WIDTH ON STANDING CT
AND WORMS CARTILAGE MORPHOLOGY
N. Segal y, E. Frick z, M. Nevitt x, J. Torner z, D. Felson k, A. Guermazi k,
D. Anderson z. y The Univ. of Kansas, Kansas City, KS, USA; z The Univ. of
Iowa, Iowa City, IA, USA; xUniv. of California, San Francisco, San
Francisco, CA, USA; k Boston Univ. Sch. of Med., Boston, MA, USA
Purpose: Due to plain radiographs acquiring 2D images of a 3D struc-
ture, patient positioning has a large impact on the apparent JSW, and
the resulting variations can cause substantial imprecision in measure-
ments. Overlapping bony structures on 2D images make JSW measured
from plain radiographs insensitive_approximately 45% of knees with at
least partial-thickness cartilage loss are graded as “completely normal.”
3D images acquired using a low-dose standing CT (SCT) scanner are
unencumbered by overlapping anatomy, potentially improving con-
current validity with MRI and obviating the need for separate radio-
graphic acquisitions at multiple beam angles. If JSW from SCTaccurately
represents cartilage morphology, the cost and duration of knee OA
clinical trials may be reduced through enabling recruitment of people
with known disease status and more sensitive evaluation of outcomes.
The purpose of this study was to assess the association between medial
tibiofemoral JSW measured on 3D SCT and WORMS cartilage mor-
phology scores.
Methods: This study was conducted ancillary to the 84-month visit of
the Multicenter Osteoarthritis Study (MOST), an NIH-funded longi-
tudinal observational study of community-dwelling men and women
with or at risk for knee osteoarthritis. Participants at the Iowa site were
eligible if they had bilateral, standing ﬁxed-ﬂexion knee radiographs in
the prior 6 months, knees discordant for KL grade and with KL<4 (to
include a range of JSW) and a distal thigh width on PA radiographs that
did not exceed the 38.1cm SCT gantry width. Out of 83 participants who
met inclusion criteria, the ﬁrst 20 volunteers were enrolled. For SCT, a
commercial scanner (PedCAT, Curvebeam LLC, Warrington, PA) was
modiﬁed to enable imaging of bilateral knees in a standing ﬁxed-ﬂexion
conﬁguration. A custom radiolucent positioning system was used to
maintain foot external rotation and ﬁxed knee ﬂexion angles. The
scanner produced pulsed cone-beam x-ray (effective dose equivalent
0.1 mSv) on a 30x30 cm amorphous silicon ﬂat-panel detector
(0.194mm pixel size) over a 360 projection angle. A 3D axial CT dataset
was reconstructed from initial cone-beam projection images, and bones
were segmented in a semi-automatedmanner. Medial tibiofemoral JSW
was assessed on ﬁxed ﬂexion SCT by measuring the intra-articular
closest distances between points on the tibiofemoral bony articular
margins (Figure 1). Knee MRI was completed using a 1-Tesla ONI
OrthOne extremity MRI scanner (GE Healthcare, Waukesha, WI).
Experienced radiologists assessed the medial tibiofemoral cartilage
morphology on axial and sagittal proton-density weighted fat-sup-
pressed (PDFS) fast spin echo sequences and a coronal STIR sequence,
using the WORMS system (0-6). The associations between the percent
articular surface area with JSW <2.5mm and theWORMS-CM scores for
the central medial tibia and femor were assessed using Spearman's rho,
including one randomly selected knee per participant to avoid intra-
participant covariance between limbs. A sensitivity analysis, using the
